Choosing a trusted provider is crucial
Eligible patients had initiated treatment and had 1 pharmacy claim of any dose strength of semaglutide 2.4 mg or tirzepatide in the US Komodo Health database between June 4, 2021 (approval date of semaglutide 2.4 mg), and December 15, 2023
Recently, these drugs and their weight loss drug counterparts (Wegovy, Zepbound et al.) are extremely popular as an appetite suppressant and medication weight loss drug
After first use, refrigerate and discard after 28 days
Vomiting and Heartburn Vomiting is less common than nausea but can occur if a dose is increased too quickly or if you eat past the point of fullness
While the sample size of 18 women was small, the results were impressive to say the least